
Tag: cannabis-based


Ukrainian patients’, human rights and veterans’ organizations deserve legalization of cannabis-based medicines says Inna Ivanenko, executive director of Patients of Ukraine

NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case

New FDA cannabis guidance (Newsletter: January 24, 2023)

Cannabis shows promise as treatment for borderline personality disorder (BPD)

FDA Releases Final Guidance For Cannabis Drug Development As Advocates Await Hemp And CBD Rules

One in five taking part in Dry January turn to cannabis instead – survey

Cruelty-free CBD: cannabis-based beauty products that are vegan-friendly

Report reveals why many UK doctors are not prescribing medical cannabis

Cost analysis of cannabis on the NHS to launch next month

Over 89,000 private cannabis prescriptions since 2018, less than five on the NHS

US|There’s Hope for Cannabis-Based Alzheimer’s Treatments

US|Using THC to Enhance Orgasms

ISRAEL | Israeli Researchers Study Cannabis for the Treatment of Endometriosis

First UK patient gets legal medicinal cannabis dispensed and delivered.

GERMANY | Germany seeks medical marijuana producers for home grown supply

USA | New cannabis patch for fibromyalgia pain and diabetic nerve pain treatment

How does THC work in the body? Researchers share new scientific insights

UK Doctors’ Perspectives on Challenges to Prescribing Medical Cannabis: A New Report

Cannabis year-in-review: 22 takeaways from 2022

USA|Epileptic 5-Year-Old May Now Bring Cannabis-Based Medicine to School

France|France launches committee to evaluate medical cannabis market

What Is CBD Oil, and Does It Really Work?

Australia|Drug expert supports current Australian medicinal cannabis policies

How cannabis topicals work and why they’re not yet regulated

SA|Africa’s First Medical Cannabis Dispensary Opens in South Africa | TalkingDrugs

MPs given lessons in using medical cannabis – NZ Herald

Revealed: ‘major disconnect’ between NHS and private cannabis prescribing

UK – VOLTE FACE: WHAT DOES THE NEW MHRA GUIDANCE MEAN FOR THE CANNABIS SECTOR?

MedReleaf NZ Awarded New Zealand Supply Licence

New research holds promise for cannabis as treatment for Tourette’s syndrome

Estonian district votes to get cannabis leaf flag – BBC News

Up to a third of UK children receiving end-of-life care may be using cannabis

What does a legal cannabis market in Germany mean for medical access?

Beginner’s guide to cannabis | Well+Good

Officials advise ‘patience’ as cannabis dispensing service launches on Isle of Man

NHS Advisory On Medical Cannabis & Over The Counter CBD Products

New report reveals why many UK doctors are not prescribing medical cannabis

Avida Global to manufacture medical cannabis products in the UK

Jazz Pharma to present new research findings on Epidyolex

Irish endometriosis patient celebrates cannabis prescription success

Is the government finally recognising the potential of a medicinal cannabis industry?

Medical cannabis in the workplace – everything you need to know

What patients want from future cannabis research – study

Will the Real Mary Jane Please Stand Up? – Cannabis vs. Sativex vs. Marinol vs. Epidiolex

Supply chain security considerations for cannabis-based products

Leva Clinic set to expand to reach more chronic pain patients

Global Cannabis-Based Alcoholic Beverages Market Outlook to 2030 – Market Opportunities, Strategies, Trends, Companies – ResearchAndMarkets.com

2022 Cannabis-based Alcoholic Beverages Market Report – Data, Growth Trends and Outlook to 2029 – ResearchAndMarkets.com

Crowdfunder launched for key study into cost-benefits of cannabis on NHS

Crowdfunder launched for key study into cost-benefits of cannabis on NHS

What are the benefits of CBD for Parkinson’s disease?

Grow Pharma apologises for price rises, blaming ‘escalating costs’

Japanese health ministry panel recommends allowing use of cannabis-based medicine

CBPM: Products for specific health conditions to enter the market

Global Legal Cannabis Market Size, Trends & Analysis Report 2022-2030: Regulatory Scenario, Consumption Pattern, Potential Trade Opportunities, Case Studies, End-users, Competitive Landscape – ResearchAndMarkets.com

Medical cannabis could help tackle opioid crisis, says study

Autistic Adults Have a Higher Quality of Life with Medical Marijuana Says New Study

Adults benefit from medical cannabis for autism

UK data shows medical cannabis improves quality of life in autistic adults

Sana Healthcare to launch UK’s first condition-specific cannabis formulary

Anti sickness for pregnancy – Cannabis may hold the key

Does CBD help with arthritis?

Cannabis-based Sativex to be available on NHS in Scotland

UK supply of Bedrocan cannabis oils ‘welcome news’ for patients

Cannabis-based Sativex to be available on NHS in Scotland

CBD could replace opioids as treatment for arthritis – study

Finding the right balance: the benefits of mixing THC and CBD flower

King’s College London Begins 6,000-Person Study on Cannabis, Mental Health

Ramm Pharma buys Polish hemp firm from TGOD for CA$1.2 million

Will Britain legalise cannabis?

Beginner’s Tips For Consuming Hemp-Based CBD Products

Endometriosis Flare-Up: Medical cannabis saves lives, says Mum

A case for cannabis: Why medicinal access and supply must be fixed

Alert – Medical Cannabsi Agency of New Zealand: Pesticide testing of non-imported starting material for export, cannabis-based ingredients and medicinal cannabis products

Can medical cannabis become the next dementia medication UK researchers ask?

The Top Cannabis-Based Products in 2022 – Who Made the List?

Jazz Pharma to trial Epidyolex as treatment for Doose syndrome

Missouri Medical Cannabis Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com

Metrc Snag Alabama.. bringing them up to 23 State contracts

North America Legal Marijuana Market Size, Share & Trends Analysis Report 2022-2030 – ResearchAndMarkets.com

CBD and epilepsy – study confirms whole-plant benefits

UK’s first patient conference to be held for Medical Cannabis

UK: All Party Parliamentary Group – for CBD (Cannabidiol) products to present their recommendations

What are the therapeutic benefits of terpenes?

Metrc Grab Rhode Island Contract

Michigan Awards $20 Million In Marijuana Tax-Funded Grants To Fund Veterans-Focused Research

Cannabis-based drug Sativex fails latest clinical trial

Metrc Announces New Track-And-Trace Government Contract with the State of Rhode Island

Over 80% of UK medical cannabis patients say they experience stigma

Wellnex Life teams up with OneLife Botanicals to penetrate Australia’s medicinal cannabis market

Medical Cannabis Company Sunshine Coast Tikun Oceana, formerly known as Medifarm Calls In The Administrators

Research shows promise for CBD in paediatric autism

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

UK medical cannabis model “inadequate” and “unsustainable” for patients

Aphios® Pharma LLC to Host Webinar on the Business of Cannabis as a Pharmaceutical Medicine on Thursday, July 14, 2022 at 12:00 pm EST

Journal Club: Can medical cannabis help anxiety and depression?

Using Cannabis for Anxiety

Legal High: Switzerland to Lift Ban on Legal Cannabis
